Ancestral Sequence Reconstruction to Enable Biocatalytic Synthesis of Azaphilones
- PMID: 39441831
- PMCID: PMC11923553
- DOI: 10.1021/jacs.4c08761
Ancestral Sequence Reconstruction to Enable Biocatalytic Synthesis of Azaphilones
Abstract
Biocatalysis can be powerful in organic synthesis but is often limited by enzymes' substrate scope and selectivity. Developing a biocatalytic step involves identifying an initial enzyme for the target reaction followed by optimization through rational design, directed evolution, or both. These steps are time consuming, resource-intensive, and require expertise beyond typical organic chemistry. Thus, an effective strategy for streamlining the process from enzyme identification to implementation is essential to expanding biocatalysis. Here, we present a strategy combining bioinformatics-guided enzyme mining and ancestral sequence reconstruction (ASR) to resurrect enzymes for biocatalytic synthesis. Specifically, we achieve an enantioselective synthesis of azaphilone natural products using two ancestral enzymes: a flavin-dependent monooxygenase (FDMO) for stereodivergent oxidative dearomatization and a substrate-selective acyltransferase (AT) for the acylation of the enzymatically installed hydroxyl group. This cascade, stereocomplementary to established chemoenzymatic routes, expands access to enantiomeric linear tricyclic azaphilones. By leveraging the co-occurrence and coevolution of FDMO and AT in azaphilone biosynthetic pathways, we identified an AT candidate, CazE, and addressed its low solubility and stability through ASR, obtaining a more soluble, stable, promiscuous, and reactive ancestral AT (AncAT). Sequence analysis revealed AncAT as a chimeric composition of its descendants with enhanced reactivity likely due to ancestral promiscuity. Flexible receptor docking and molecular dynamics simulations showed that the most reactive AncAT promotes a reactive geometry between substrates. We anticipate that our bioinformatics-guided, ASR-based approach can be broadly applied in target-oriented synthesis, reducing the time required to develop biocatalytic steps and efficiently access superior biocatalysts.
Conflict of interest statement
The authors declare no competing financial interest.
Figures





Similar articles
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Jan 9;1:CD011535. doi: 10.1002/14651858.CD011535.pub3. PMID: 29271481 Free PMC article. Updated.
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4. Cochrane Database Syst Rev. 2021. Update in: Cochrane Database Syst Rev. 2022 May 23;5:CD011535. doi: 10.1002/14651858.CD011535.pub5. PMID: 33871055 Free PMC article. Updated.
-
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2. Cochrane Database Syst Rev. 2017. PMID: 28535331 Free PMC article.
-
Factors that impact on the use of mechanical ventilation weaning protocols in critically ill adults and children: a qualitative evidence-synthesis.Cochrane Database Syst Rev. 2016 Oct 4;10(10):CD011812. doi: 10.1002/14651858.CD011812.pub2. Cochrane Database Syst Rev. 2016. PMID: 27699783 Free PMC article.
References
-
- Huffman MA; Fryszkowska A; Alvizo O; Borra-Garske M; Campos KR; Canada KA; Devine PN; Duan D; Forstater JH; Grosser ST, et al. , Design of an in vitro biocatalytic cascade for the manufacture of islatravir. Science 2019, 366 (6470), 1255–1259. - PubMed
-
- Fryszkowska A; An C; Alvizo O; Banerjee G; Canada KA; Cao Y; DeMong D; Devine PN; Duan D; Elgart DM, et al. , A chemoenzymatic strategy for site-selective functionalization of native peptides and proteins. Science 2022, 376 (6599), 1321–1327. - PubMed
-
- Buller R; Lutz S; Kazlauskas RJ; Snajdrova R; Moore JC; Bornscheuer UT, From nature to industry: Harnessing enzymes for biocatalysis. Science 2023, 382 (6673), eadh8615. - PubMed
-
- Chen K; Arnold FH, Engineering new catalytic activities in enzymes. Nat. Catal 2020, 3 (3), 203–213.
-
- Wang Y; Xue P; Cao M; Yu T; Lane ST; Zhao H, Directed Evolution: Methodologies and Applications. Chem. Rev 2021, 121 (20), 12384–12444. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources